Physician

Sloan Whitmore Rush, M.D.

According to 2025 Medicare claims, Sloan Rush, M.D. (NPI: 1356535678) practices ophthalmology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is PANHANDLE EYE GROUP, LLP (NPI: 1760571723; TIN: 752741195) and primary practice location at 79106-1807. Rush is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Rush's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 972 traditional Medicare patients, billed 4,108 HCPCS/CPT codes, and received $470,863 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 881 prescription claims across 288 beneficiaries totaling $79,091 in drug costs, led by Restasis (Cyclosporine). 2017 DME data shows 17 claims. Open Payments data shows 6 records totaling $19,343. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $536,204 to $470,863. Similarly, Part D prescription costs have fallen sharply in recent years, from $179,997 to $79,091. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	994	3,655	$536,204
2016	1,105	4,157	$607,233
2017	1,173	4,503	$654,883
2018	1,099	4,463	$619,652
2019	1,116	4,907	$624,297
2020	888	3,492	$430,125
2021	955	3,922	$468,433
2022	855	3,310	$419,397
2023	903	3,753	$484,760
2024	972	4,108	$470,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	498	1,414	$179,997
2016	552	1,573	$211,822
2017	495	1,532	$199,754
2018	262	1,140	$140,578
2019	247	1,036	$152,291
2020	228	1,010	$124,656
2021	208	831	$102,101
2022	158	577	$59,444
2023	183	674	$57,241
2024	288	881	$79,091

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	12	$515
2016	14	14	$660
2017	17	17	$851
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	270	480	$396
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	265	265	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	524	593	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	486	744	$61
92025	Ct scan of cornea	414	501	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	32	1,170	$24,113
Prednisolone Acetate	Prednisolone Acetate	338	12,180	$15,170
Miebo	Perfluorohexyloctane/Pf	13	690	$13,808
Loteprednol Etabonate	Loteprednol Etabonate	26	795	$2,945
Diclofenac Sodium	Diclofenac Sodium	81	2,535	$1,410

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$7,048	Alcon Research LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$12,295	Alcon Research LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sloan Whitmore Rush, M.D.?

Tedicare shows public-source Medicare data for Sloan Whitmore Rush, M.D. (NPI 1356535678), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sloan Whitmore Rush, M.D. have ACO affiliation data?

Sloan Whitmore Rush, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Sloan Whitmore Rush, M.D.?

Sloan Whitmore Rush, M.D. is linked to PANHANDLE EYE GROUP, LLP (billing NPI 1760571723) in the available physician profile data.

Does Sloan Whitmore Rush, M.D. have Open Payments data?

Sloan Whitmore Rush, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.